5-amino-1MQ (5-amino-1methylquinolinium), similar to methylquinolinium, acts as a short peptide that blocks the cytosolic enzyme nicotinamide N-methyltransferase (NNMT)
Individuals with malabsorption conditions, severe deficiency, or those who havent responded to oral supplements typically benefit most from injections
Rather than supplying additional precursors, it limits NAD+ depletion by inhibiting NNMT, allowing exploration of upstream metabolic control
And people may need vitamin B 12 injections to lessen this risk of deficiency, leading to pernicious anemia
This post breaks down what is currently known about AOD 9604, highlights potential risks, and offers practical advice for those interested in its use
The KruskalWallis test was used to evaluate differences in gross morphological scores, histopathological scores, and lameness duration across all four treatment groups